Cavalier Investments LLC Makes New Investment in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Cavalier Investments LLC bought a new position in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 44,667 shares of the financial services provider’s stock, valued at approximately $5,383,000. iShares Nasdaq Biotechnology ETF makes up approximately 2.3% of Cavalier Investments LLC’s investment portfolio, making the stock its 10th largest holding. Cavalier Investments LLC owned about 0.07% of iShares Nasdaq Biotechnology ETF as of its most recent SEC filing.

Several other institutional investors have also bought and sold shares of IBB. McKinley Carter Wealth Services Inc. bought a new stake in shares of iShares Nasdaq Biotechnology ETF in the 4th quarter worth $29,000. Financial Advisory Service Inc. purchased a new position in shares of iShares Nasdaq Biotechnology ETF in the 4th quarter worth $32,000. Horan Capital Advisors LLC. purchased a new position in shares of iShares Nasdaq Biotechnology ETF in the 3rd quarter worth $34,000. Capital Planning Advisors LLC purchased a new position in shares of iShares Nasdaq Biotechnology ETF in the 3rd quarter worth $36,000. Finally, Advanced Asset Management Advisors Inc purchased a new position in shares of iShares Nasdaq Biotechnology ETF in the 4th quarter worth $36,000. 84.58% of the stock is owned by institutional investors and hedge funds.

Separately, ValuEngine downgraded iShares Nasdaq Biotechnology ETF from a “buy” rating to a “hold” rating in a research note on Tuesday, October 22nd.

IBB stock opened at $121.95 on Friday. iShares Nasdaq Biotechnology ETF has a 1 year low of $96.03 and a 1 year high of $123.74. The stock’s fifty day moving average price is $119.79 and its 200-day moving average price is $110.99.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Further Reading: How Does the Quiet Period Work?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply